Publications
5808 Results
- Journal / Conference
- ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), oral
- Year
- 2025
- Research Committee(s)
- Breast
- Study Number(s)
- S1416
Concordance Between Liquid and Tissue-Based Assessment of Somatic Homologous Recombination Deficiency (HRD) in Triple-Negative Breast Cancer (TNBC) from SWOG S1416 Trial
- Journal / Conference
- JNCI Monographs Mar 1;2025(68):65-72
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989039
- PMC
- PMC11848034
- Study Number(s)
- S1415CD
Intracluster Correlation Coefficients from Cluster Randomized Trials Conducted within the NCI Community Oncology Research Program (NCORP)
- Journal / Conference
- Leukemia
- Year
- 2025
- Research Committee(s)
- Leukemia
- PMID
- PMID39870766
- Study Number(s)
- S1203
Probability of remission with reinduction with 7+3 versus high-dose ara-C: Analysis of SWOG Trial S1203
- Journal / Conference
- Cancer
- Year
- 2025
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID39932777
- PMC
- PMC11812894
- Study Number(s)
- S1505
Chemotherapy Dose Density is Prognostic for Overall Survival in Patients with Resectable Pancreas Cancer: A Landmark Analysis of SWOG 1505
- Journal / Conference
- NPJ Precision Oncology
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID39856213
- PMC
- PMC11759674
- Study Number(s)
- S1609
Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Metastatic Basal Cell Carcinoma
- Journal / Conference
- European Urology 2025 Nov;88(5):430-434. doi: 10.1016/j.eururo.2025.03.023. Epub 2025 May 22.
- Year
- 2025
- Research Committee(s)
- Genitourinary
- PMID
- PMID40404526
- Study Number(s)
- S1605
Urine Tumor DNA to Stratify the Risk of Recurrence in Patients Treated with Atezolizumab for Bacillus Calmette-Guérin-unresponsive Non-muscle-invasive Bladder Cancer
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):14-21
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Melanoma
- PMID
- PMID39989038
- PMC
- PMC11848031
- Study Number(s)
- S1404
Best practices and pragmatic approaches for PRO/QOL measures in cancer clinical trials
- Journal / Conference
- Journal of the National Cancer Institute Monographs Mar 1;2025(68):22-29
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID39989043
- PMC
- PMC11848030
Design and Analysis Considerations for Investigating Patient Subgroups of Interest Within Cancer Clinical Trials
- Journal / Conference
- JNCI Cancer Spectr. 2025 Apr 30;9(3):pkaf033. doi: 10.1093/jncics/pkaf033.
- Year
- 2025
- Research Committee(s)
- Cancer Care Delivery and Leukemia
- PMID
- PMID40238217
- PMC
- PMC12121638
Guideline-Concordant Treatment among Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)
- Journal / Conference
- Journal for ImmunoTherapy of Cancer 2025 Jun 30;13(6):e011760. doi: 10.1136/jitc-2025-011760
- Year
- 2025
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID40588371
- PMC
- PMC12211841
- Study Number(s)
- S1609